Other headlines:PETNET extends supply of radioisotopeFonar customer logs fifth UpRight
Dr. Paul E. Berger has cut all formal ties with NightHawk Radiology, a company he helped found eight years ago. Berger stepped down June 8 as nonexecutive chairman of the board, a position he has held since Nov. 15, when he resigned as CEO of the company. In connection with his resignation this week from the board, Berger informed NightHawk that he could no longer support the direction, policies, business strategies, and initiatives that the company has adopted, according to a NightHawk filing with the Securities and Exchange Commission.
Siemens subsidiary PETNET Solutions will supply an experimental PET radioisotope for the phase II and III trials examining its value as a cardiac perfusion agent. The radiotracer, BMS747158, is a novel fluorine-18-labeled tracer developed by Lantheus Medical Imaging for myocardial perfusion imaging in subjects under rest and stress conditions. Lantheus is running the trials. PETNET Solutions operates a network of 52 radiopharmacies and distribution centers worldwide that manufacture and distribute PET biomarkers.
If repeat business is the most sincere compliment, few companies get more praise than Fonar, at least from Tampa-based Rose Radiology. The 10-center radiology chain on Florida's west coast has bought its fifth UpRight MR scanner from Fonar. Rose was among the first to begin uing an UpRight MR. This scanner, which began operating about seven years ago, was the first installed in Florida and the second in the world, according to Fonar.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Stroke MRI Study Assesses Impact of Motion Artifacts Upon AI and Radiologist Lesion Detection
July 16th 2025Noting a 7.4 percent incidence of motion artifacts on brain MRI scans for suspected stroke patients, the authors of a new study found that motion artifacts can reduce radiologist and AI accuracy for detecting hemorrhagic lesions.